Type of Posting: Publication Announcement
Posting Date: 23–Nov–2022
On November 18, 2022, Enoxaparin Sodium monograph revision via Interim Revision Announcement (IRA) was posted in USP-NF with an official date of January 1, 2023. According to the decision from Biologics Monographs 3 – Complex Biologics and Vaccines (BIO3) Expert Committee, which is responsible for this monograph, this revision will be re-posted in USP-NF on December 16, 2022 with an official date of December 1, 2023, which is consistent with the decision of the BIO3 Expert Committee and the content of the Compendial Notice posted on September 30, 2022.
Should you have any question, please contact Julie Zhang, Team Lead (301-816-8350 or Julie.Zhang@usp.org).